# Jutro Medical Sp. z o.o.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jutro-medical-sp-z-o-o

- Industry: Healthcare IT
- Headquarters: Warsaw, Poland
- Website: www.jutromedical.com
- Total disclosed funding: $7.1M
- Latest round: Series A (Dec 2, 2025)
- Investors on record: 9

## About

Based in Warsaw, Poland, Jutro Medical Sp. z o.o. specializes in providing efficient primary healthcare services through modern clinics located in urban areas, ensuring accessible medical care for families and individuals. Founded in 2020 and headquartered in Warsaw, Poland, Jutro Medical Sp. z o.o. operates modern clinics that offer primary healthcare services. The company was established by Adam Janczewski, who serves as CEO. In March 2026, Jutro Medical Sp. z o.o. raised EUR 12 million in venture funding. Jutro Medical specializes in providing primary healthcare services through modern clinics located in urban areas across Poland. Their core offerings include free medical care under the National Health Fund (NFZ), which encompasses services such as consultations with family doctors and general practitioners, e-prescriptions, and access to a comprehensive medical history via a centralized app. The clinics are designed to eliminate long wait times, allowing patients to schedule no-queue appointments either in-person or through telemedicine. Jutro Medical's services cater primarily to families and individuals seeking accessible healthcare solutions, serving over 70,000 patients and operating in major Polish cities including Warsaw, Gdansk, Krakow, Poznan, and Wroclaw. Their commitment to patient care is evident in their team of qualified family doctors, nurses, and medical assistants, who focus on a holistic approach to health and well-being. In 2022, Jutro Medical recorded a revenue of EUR 840,993.80, with an EBITDA of EUR -3,288,137.40. The company's revenue model is anchored in the provision of healthcare services funded through the National Health Fund, which enables patients to receive consultations and treatments without direct costs. In March 2026, Jutro Medical Sp. z o.o. raised EUR 12 million in venture funding. The company will use the March 2026 funding to broaden artificial intelligence-supported primary care offerings.

## Funding rounds

- Series A, Dec 2, 2025 — Warsaw Equity, Inovo VC, KAYA, Aternus, Vinci, Fluent Ventures, naturalX Health Ventures
- Series A, Mar 7, 2025 — Inovo VC, KAYA
- Seed, Jul 24, 2021, $7.1M — Rheingau Founders, Inovo VC, Market One Capital

## Investors

- Rheingau Founders (https://capitalatlas.ai/funds/rheingau-founders) — Seed
- Inovo VC (https://capitalatlas.ai/funds/inovo-vc) — Seed, Series A
- Market One Capital (https://capitalatlas.ai/funds/market-one-capital) — Seed
- KAYA (https://capitalatlas.ai/funds/kaya) — Series A
- Warsaw Equity (https://capitalatlas.ai/funds/warsaw-equity) — Series A
- Aternus — Series A
- Vinci (https://capitalatlas.ai/funds/vinci) — Series A
- Fluent Ventures (https://capitalatlas.ai/funds/fluent-ventures) — Series A
- naturalX Health Ventures (https://capitalatlas.ai/funds/naturalx-health-ventures) — Series A